SlideShare a Scribd company logo
TETANU
S
1
Dr.T.V.RaoMD 2
What is Tetanus?
• Tetanus is an illness characterized by an acute
onset of hypertonia, painful muscular
contractions (usually of the muscles of the jaw
and neck), and generalized muscle spasms
without other apparent medical causes.
Caused by Clostridium Tetani
Gram positive
Spore-forming
Anaerobic bacilli
Dr.T.V.RaoMD 3
Causative agent
• Clostridium tetani
Left. Stained pus from a mixed anaerobic infection. At least
three different clostridia are apparent.
Right. Electron micrograph of vegetative Clostridium tetani
cells.
Dr.T.V.RaoMD 4
Morphology & Physiology
• Relatively large, Gram-positive, rod-
shaped bacteria
• Spore-forming, anaerobic.
• Found in soil, especially heavily-manured
soils, and in the intestinal tracts and
feces of various animals.
• Strictly fermentative mode of
metabolism.
Dr.T.V.RaoMD 5
6
C.tetani spores are found everywhere
• Spores of C. tetani are found in soils
throughout the world
Spores are very resistant to harsh
conditions
heat
radiation
chemicals
drying
•
•
•
•
•
• Spores can survive for a long time
in environment---100yrs possibly!
7
Methods of transmission
• C. tetani can live for years as spores in animal feces
and soil. As soon as it enters the human body
through a major or minor wound and the conditions
are anaerobic, the spores germinate and release the
toxins.
• Tetanus may follow burns, deep puncture wounds,
ear or dental infections, animal bites, abortion.
• Only the growing bacteria can produce the toxin.
• It is the only vaccine-preventable disease that is
infectious but not contagious from person to person.
8
Methods of transmission
• Tetanus may follow burns, deep puncture
wounds, ear or dental infections, animal
bites, abortion.
• Only the growing bacteria can produce
the toxin.
• It is the only vaccine-preventable
disease that is infectious but not
contagious from person to person.
C.tetani - Entry of spores
• Entry of C. tetani into the body
usually involves implantation of
spores into a wound
• After gaining entry, C. tetani spores
can persist in the body for months,
waiting for the proper low oxygen
growth conditions to develop
•
Dr.T.V.RaoMD
10
C.tetani produces toxigenic Disease
• C. tetani spores enter the body, they are again in
an oxygen-free environment where they can
germinate. The spores usually enter the body
through a deep puncture wound or cut, but
animal bites or even a splinter also can allow
spore entry. The bacteria then produce tetanus
toxins, which circulate in the body. One of the
toxins blocks nerve impulses that allow muscles
to relax. This toxin is responsible for causing
generalized tetanus, the most common form of
the disease.
Virulence & Pathogenicity
• Not pathogenic to
humans and animals by
invasive infection but by
the production of a
potent protein toxin
– tetanus toxin or
tetanospasmin
– The second exotoxin
produced is tetanolysin—
function not known.
Dr.T.V.RaoMD 11
Dr.T.V.RaoMD 12
Toxin and C.tetani
• Tetanospasmin ( exotoxin ) produced locally ,
released into bloodstream .
• Binds to peripheral motor neuron terminals & nerve
cells of ant.horn of spinal cord
• The toxin after entering axon , transported to nerve
cell body in brain stem & spinal cord – retrograde
intraneuronal transport
• Toxin – migrates across synapse – presynaptic
terminals- blocks the release of Glycine & GABA from
vesicles.
Dr.T.V.RaoMD 13
Tetanus toxin
• Produced when spores germinate and
vegetative cells grow after gaining access
to wounds. The organism multiplies
locally and symptoms appear remote
from the infection site.
• One of the three most poisonous
substances known on a weight basis, the
other two being the toxins of botulism
and diphtheria.
14
Tetanus toxin
–Tetanus toxin is produced in vitro in
amounts up to 5 to 10% of the bacterial
weight.
–Estimated lethal human dose of
Tetanospasmin = 2.5 nanograms/kg body
• Because the toxin has a specific affinity
for nervous tissue, it is referred to as a
neurotoxin. The toxin has no known
useful function to C. tetani.
• Initially binds to
peripheral nerve
terminals
• Transported within
the axon and across
synaptic junctions
until it reaches the
central nervous
system.
• Becomes rapidly
fixed to gangliosides
at the presynaptic
inhibitory motor
nerve endings, then
taken up into the
axon by endocytosis.
Dr.T.V.RaoMD 15
16
Toxic manifestations
• As growing cells of C. tetani produce
tetanospasmin at the wound site, the
toxin starts to migrate along nerves
into the Central Nervous System where
it blocks the release of inhibitory
neurotransmitters
• As a consequence of too much
“activator transmitters”, muscles are
Overstimulated to repeatedly
contract—called spastic paralysis
17
How the toxin acts
Blocks the release of inhibitory
neurotransmitters (glycine and gamma-
amino butyric acid) across the synaptic
cleft, which is required to check the
nervous impulse.
 If nervous impulses cannot be checked by
normal inhibitory mechanisms, it leads to
unopposed muscular contraction and
spasms that are characteristic of tetanus.
Symptoms
• Tetanic seizures (painful,
powerful bursts of muscle
contraction)
• if the muscle spasms affect the larynx or chest wall,
they may cause asphyxiation
• stiffness of jaw (also called lockjaw)
• stiffness of abdominal and back muscles
• contraction of facial muscles
• fast pulse
• fever
• sweating Dr.T.V.RaoMD 18
19
Patient Manifests with
• A person suffering from tetanus undergoes
convulsive muscle contractions of the jaw--
called LOCKJAW
• The contractions by the muscles of the back
and extremities may become so violent and
strong that bone fractures may occur
• The affected individual is conscious
throughout the illness, but cannot stop these
contractions
Trismus
The back muscles are
more powerful, thus
creating the arc
backward
“Oposthotonus” by Sir
Charles Bell, 1809.
Baby has neonatal
tetanus with
complete rigidity
Dr.T.V.RaoMD 21
22
Types of tetanus:
local, cephalic, generalized, neonatal
• Incubation period: 3-21 days, average 8 days.
Uncommon types:
• Local tetanus: persistent muscle contractions in the
same anatomic area as the injury, which will however
subside after many weeks; very rarely fatal; milder than
generalized tetanus, although it could precede it.
• Cephalic tetanus: occurs with ear infections or following
injuries of the head; facial muscles contractions.
23
Most common types:
Generalized tetanus
- descending pattern: lockjaw  stiffness of neck 
difficulty swallowing  rigidity of abdominal and back
muscles.
- Spasms continue for 3-4 weeks, and recovery can last for
months
- Death occurs when spasms interfere with respiration.
Neonatal tetanus:
- Form of generalized tetanus that occurs in newborn infants
born without protective passive immunity because the
mother is not immune.
- Usually occurs through infection of the unhealed umbilical
stump, particularly when the stump is cut with an unsterile
instrument.
24
Methods of diagnosis
• Based on the patient’s account and
physical findings that are
characteristic of the disease.
• Diagnostic studies generally are of
little value, as cultures of the wound
site are negative for C. tetani two-
thirds of the time.
–When the culture is positive, it
confirms the diagnosis of tetanus
Dr.T.V.RaoMD 25
Diagnosis
• Tests that may be performed include the
following:
–Culture of the wound site (may be
negative even if tetanus is present)
–Tetanus antibody test
–Other tests may be used to rule out
meningitis, rabies, strychnine
poisoning, or other diseases with
similar symptoms.
26
Clinical treatment
• If treatment is not sought early, the disease is
often fatal.
• The bacteria are killed with antibiotics, such
as penicillin or tetracycline; further toxin
production is thus prevented.
• The toxin is neutralized with shots of tetanus
immune globulin, TIG.
• Other drugs may be given to provide sedation,
relax the muscles and relieve pain.
• Due to the extreme potency of the toxin,
immunity does not result after the disease.
years.
Method of prevention - Immunization
• A person recovering from tetanus should begin active
immunization with tetanus toxoid (Td) during
convalescence.
• The tetanus toxoid is a formalin-inactivated toxin,
with an efficiency of approx. 100%.
• The DTaPe includes tetanus, diphtheria and pertussis
toxoids; it is routinely given in the US during
childhood. After 7 years of age, only Td needs to be
administered.
• Because the antitoxin levels decrease over time,
booster immunization shots are needed every 10
29
Dr.T.V.RaoMD 28
Other supporting measures?
• Remove and destroy the source of the toxin through
surgical exploration and cleaning of the wound
(debridement).
• Bed rest with a nonstimulating environment (dim
light, reduced noise, and stable temperature) may be
recommended.
• Sedation may be necessary to keep the affected
person calm.
• Respiratory support with oxygen, endotracheal tube,
and mechanical ventilation may be necessary.
Dr.T.V.RaoMD 29
Specific Treatment
b. Wound should be debrided widely.
c. Maintain an adequate airway.
d. Employ sedation (as indicated) or muscle. relaxant.
e. Active immunization. should be initiated concurrently
with therapy.
6.Destruction of environmental spores:
- esp. in operating theatres.
- Special air-flow equipment and filtered ventilation. -
Reduce airborne particles. Surgical instruments and
dressing sterilization (use of autoclaves). Disinfect.
e.g. formaldehyde.
Dr.T.V.RaoMD 30
Tetanus Toxoid
• Formalin-inactivated tetanus toxin
• Schedule Three or four doses + booster
Booster every 10 years
• Efficacy Approximately 100%
• Duration Approximately 10 years
• Should be administered with diphtheria toxoid as
DTaP,DT, Td, or Tdap
Prognosis in Infected
• Prognosis is dependent on incubation period, time
from spore inoculation to first symptom, and time
from first symptom to first tetanic spasm.
• In general, shorter intervals indicate more severe
tetanus and a poorer prognosis.
• Patients usually survive tetanus and return to their
pre disease state of health.
• Recovery is slow and usually occurs over 2-4 months.
• Clinical tetanus does not produce a state of
immunity; therefore, patients who survive the
disease require active immunization with tetanus
toxoid to prevent a recurrence.
Dr.T.V.RaoMD 32
Care in the Hospital to eliminate
C.tetani spores
.Destruction of environmental spores:
- Specially in operating theatres.
- Special air-flow equipment and filtered
ventilation. - Reduce airborne
particles. Surgical instruments and
dressing sterilization (use of
autoclaves). Disinfect. e.g.
formaldehyde.
Tetanus is a Vaccine Preventable Disease-
Do vaccinate without fail
Dr.T.V.RaoMD 33

More Related Content

DOCX
Tetanus
PDF
Tetanus 120405220242-phpapp01
PPTX
Tetanus -Basics
PPTX
Tetanus
PPT
Tetanus.ppt
PPT
Tetanus.ppt
PPT
Tetanus Mahmadamin ATSMU_2019
PPT
Tetanus - Mymensingh Medi+. .pptx
Tetanus
Tetanus 120405220242-phpapp01
Tetanus -Basics
Tetanus
Tetanus.ppt
Tetanus.ppt
Tetanus Mahmadamin ATSMU_2019
Tetanus - Mymensingh Medi+. .pptx

Similar to tetanus.pptx, introduction, pathophysiology (20)

PPT
TETANUS NOTES.pptx. medicine
PPTX
NEONATAL TETANUS.pptx for pediatrics rev
PPT
Tetanus.ppt
PPTX
CLOSTRIDIUM TETANI Microbial disease.pptx
PPTX
PPTX
titnass.pptx
PPT
!Tetanus m
PPT
!Tetanus M.ppt
PPT
100018171.9.20.ppt
PPTX
Tetanus
PPT
Tetanus and Anaerobic infection
PDF
2nd sem tetnus & pneumonia.pdf
PPT
Clostridial toxins: tetanus toxin
PPT
!Tetanus m
PPTX
Power Point of Tetanus and vaccine -1.pptx
PPTX
Tetanus also called: lockjaw
PPTX
tetanus.pptx
PPTX
Definition and principles of Management of neonatal tetanus,
PPTX
TETANUS NEONATORUM12345669068594793739.pptx
PPTX
TETANUS NEONATORUM12345669068594793739.pptx
TETANUS NOTES.pptx. medicine
NEONATAL TETANUS.pptx for pediatrics rev
Tetanus.ppt
CLOSTRIDIUM TETANI Microbial disease.pptx
titnass.pptx
!Tetanus m
!Tetanus M.ppt
100018171.9.20.ppt
Tetanus
Tetanus and Anaerobic infection
2nd sem tetnus & pneumonia.pdf
Clostridial toxins: tetanus toxin
!Tetanus m
Power Point of Tetanus and vaccine -1.pptx
Tetanus also called: lockjaw
tetanus.pptx
Definition and principles of Management of neonatal tetanus,
TETANUS NEONATORUM12345669068594793739.pptx
TETANUS NEONATORUM12345669068594793739.pptx
Ad

More from kasempaeberty (16)

PPTX
TOPIC ONE-HP HEALTH AS A CONCEPT.pptx public health care
PPTX
THE HEALTH PROMOTER.pptxpublic health care
PPTX
ETHICAL ISSUES IN HP.pptxhpublic healthy
PPTX
GINGIVAL INFLAMMATION.pptx information k
PPT
Meningitis.ppt contains information on meningitis
PPT
epilepsy.ppt contains information on epilepsy
DOCX
OPHTHALMOLOGY_EDEN_INSTITUTE of medicine.docx
PPTX
3 Nephrotic Syndrome1.pptx information on
PPTX
Somatoform disorders.pptx definition, pathophysiology
PDF
5. Burns and Skin Grafts.pdf this slides contains
PPT
RHEUMATIC FEVER and RHD 2 FOR MLS.ppt rule
PPT
Infective endocarditis.ppt infective endocarditis
PDF
unit 3 Acute & Chronic Inflammation (1).pdf
PPTX
UNIT 5 DRUGS ACTING ON INTESTINAL TRACT-1.pptx
PPT
History Taking final.ppt( all courses history taking)
PPTX
2 TUBERCULOSIS 2.pptx ( introduction to management)
TOPIC ONE-HP HEALTH AS A CONCEPT.pptx public health care
THE HEALTH PROMOTER.pptxpublic health care
ETHICAL ISSUES IN HP.pptxhpublic healthy
GINGIVAL INFLAMMATION.pptx information k
Meningitis.ppt contains information on meningitis
epilepsy.ppt contains information on epilepsy
OPHTHALMOLOGY_EDEN_INSTITUTE of medicine.docx
3 Nephrotic Syndrome1.pptx information on
Somatoform disorders.pptx definition, pathophysiology
5. Burns and Skin Grafts.pdf this slides contains
RHEUMATIC FEVER and RHD 2 FOR MLS.ppt rule
Infective endocarditis.ppt infective endocarditis
unit 3 Acute & Chronic Inflammation (1).pdf
UNIT 5 DRUGS ACTING ON INTESTINAL TRACT-1.pptx
History Taking final.ppt( all courses history taking)
2 TUBERCULOSIS 2.pptx ( introduction to management)
Ad

Recently uploaded (20)

PDF
focused on the development and application of glycoHILIC, pepHILIC, and comm...
PPTX
Medical Law and Ethics powerpoint presen
PDF
Lecture on Anesthesia for ENT surgery 2025pptx.pdf
PPTX
Hearthhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhh
PPTX
CHEM421 - Biochemistry (Chapter 1 - Introduction)
PDF
OSCE SERIES ( Questions & Answers ) - Set 3.pdf
PPTX
Cardiovascular - antihypertensive medical backgrounds
PPTX
09. Diabetes in Pregnancy/ gestational.pptx
DOCX
PEADIATRICS NOTES.docx lecture notes for medical students
PPTX
preoerative assessment in anesthesia and critical care medicine
PPT
neurology Member of Royal College of Physicians (MRCP).ppt
PPTX
Radiation Dose Management for Patients in Medical Imaging- Avinesh Shrestha
PPTX
1. Basic chemist of Biomolecule (1).pptx
PPTX
Human Reproduction: Anatomy, Physiology & Clinical Insights.pptx
PPTX
Epidemiology of diptheria, pertusis and tetanus with their prevention
PPTX
Enteric duplication cyst, etiology and management
PDF
Oral Aspect of Metabolic Disease_20250717_192438_0000.pdf
PDF
Comparison of Swim-Up and Microfluidic Sperm Sorting.pdf
PPTX
HYPERSENSITIVITY REACTIONS - Pathophysiology Notes for Second Year Pharm D St...
PDF
OSCE SERIES - Set 7 ( Questions & Answers ).pdf
focused on the development and application of glycoHILIC, pepHILIC, and comm...
Medical Law and Ethics powerpoint presen
Lecture on Anesthesia for ENT surgery 2025pptx.pdf
Hearthhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhh
CHEM421 - Biochemistry (Chapter 1 - Introduction)
OSCE SERIES ( Questions & Answers ) - Set 3.pdf
Cardiovascular - antihypertensive medical backgrounds
09. Diabetes in Pregnancy/ gestational.pptx
PEADIATRICS NOTES.docx lecture notes for medical students
preoerative assessment in anesthesia and critical care medicine
neurology Member of Royal College of Physicians (MRCP).ppt
Radiation Dose Management for Patients in Medical Imaging- Avinesh Shrestha
1. Basic chemist of Biomolecule (1).pptx
Human Reproduction: Anatomy, Physiology & Clinical Insights.pptx
Epidemiology of diptheria, pertusis and tetanus with their prevention
Enteric duplication cyst, etiology and management
Oral Aspect of Metabolic Disease_20250717_192438_0000.pdf
Comparison of Swim-Up and Microfluidic Sperm Sorting.pdf
HYPERSENSITIVITY REACTIONS - Pathophysiology Notes for Second Year Pharm D St...
OSCE SERIES - Set 7 ( Questions & Answers ).pdf

tetanus.pptx, introduction, pathophysiology

  • 2. Dr.T.V.RaoMD 2 What is Tetanus? • Tetanus is an illness characterized by an acute onset of hypertonia, painful muscular contractions (usually of the muscles of the jaw and neck), and generalized muscle spasms without other apparent medical causes.
  • 3. Caused by Clostridium Tetani Gram positive Spore-forming Anaerobic bacilli Dr.T.V.RaoMD 3
  • 4. Causative agent • Clostridium tetani Left. Stained pus from a mixed anaerobic infection. At least three different clostridia are apparent. Right. Electron micrograph of vegetative Clostridium tetani cells. Dr.T.V.RaoMD 4
  • 5. Morphology & Physiology • Relatively large, Gram-positive, rod- shaped bacteria • Spore-forming, anaerobic. • Found in soil, especially heavily-manured soils, and in the intestinal tracts and feces of various animals. • Strictly fermentative mode of metabolism. Dr.T.V.RaoMD 5
  • 6. 6 C.tetani spores are found everywhere • Spores of C. tetani are found in soils throughout the world Spores are very resistant to harsh conditions heat radiation chemicals drying • • • • • • Spores can survive for a long time in environment---100yrs possibly!
  • 7. 7 Methods of transmission • C. tetani can live for years as spores in animal feces and soil. As soon as it enters the human body through a major or minor wound and the conditions are anaerobic, the spores germinate and release the toxins. • Tetanus may follow burns, deep puncture wounds, ear or dental infections, animal bites, abortion. • Only the growing bacteria can produce the toxin. • It is the only vaccine-preventable disease that is infectious but not contagious from person to person.
  • 8. 8 Methods of transmission • Tetanus may follow burns, deep puncture wounds, ear or dental infections, animal bites, abortion. • Only the growing bacteria can produce the toxin. • It is the only vaccine-preventable disease that is infectious but not contagious from person to person.
  • 9. C.tetani - Entry of spores • Entry of C. tetani into the body usually involves implantation of spores into a wound • After gaining entry, C. tetani spores can persist in the body for months, waiting for the proper low oxygen growth conditions to develop • Dr.T.V.RaoMD
  • 10. 10 C.tetani produces toxigenic Disease • C. tetani spores enter the body, they are again in an oxygen-free environment where they can germinate. The spores usually enter the body through a deep puncture wound or cut, but animal bites or even a splinter also can allow spore entry. The bacteria then produce tetanus toxins, which circulate in the body. One of the toxins blocks nerve impulses that allow muscles to relax. This toxin is responsible for causing generalized tetanus, the most common form of the disease.
  • 11. Virulence & Pathogenicity • Not pathogenic to humans and animals by invasive infection but by the production of a potent protein toxin – tetanus toxin or tetanospasmin – The second exotoxin produced is tetanolysin— function not known. Dr.T.V.RaoMD 11
  • 12. Dr.T.V.RaoMD 12 Toxin and C.tetani • Tetanospasmin ( exotoxin ) produced locally , released into bloodstream . • Binds to peripheral motor neuron terminals & nerve cells of ant.horn of spinal cord • The toxin after entering axon , transported to nerve cell body in brain stem & spinal cord – retrograde intraneuronal transport • Toxin – migrates across synapse – presynaptic terminals- blocks the release of Glycine & GABA from vesicles.
  • 13. Dr.T.V.RaoMD 13 Tetanus toxin • Produced when spores germinate and vegetative cells grow after gaining access to wounds. The organism multiplies locally and symptoms appear remote from the infection site. • One of the three most poisonous substances known on a weight basis, the other two being the toxins of botulism and diphtheria.
  • 14. 14 Tetanus toxin –Tetanus toxin is produced in vitro in amounts up to 5 to 10% of the bacterial weight. –Estimated lethal human dose of Tetanospasmin = 2.5 nanograms/kg body • Because the toxin has a specific affinity for nervous tissue, it is referred to as a neurotoxin. The toxin has no known useful function to C. tetani.
  • 15. • Initially binds to peripheral nerve terminals • Transported within the axon and across synaptic junctions until it reaches the central nervous system. • Becomes rapidly fixed to gangliosides at the presynaptic inhibitory motor nerve endings, then taken up into the axon by endocytosis. Dr.T.V.RaoMD 15
  • 16. 16 Toxic manifestations • As growing cells of C. tetani produce tetanospasmin at the wound site, the toxin starts to migrate along nerves into the Central Nervous System where it blocks the release of inhibitory neurotransmitters • As a consequence of too much “activator transmitters”, muscles are Overstimulated to repeatedly contract—called spastic paralysis
  • 17. 17 How the toxin acts Blocks the release of inhibitory neurotransmitters (glycine and gamma- amino butyric acid) across the synaptic cleft, which is required to check the nervous impulse.  If nervous impulses cannot be checked by normal inhibitory mechanisms, it leads to unopposed muscular contraction and spasms that are characteristic of tetanus.
  • 18. Symptoms • Tetanic seizures (painful, powerful bursts of muscle contraction) • if the muscle spasms affect the larynx or chest wall, they may cause asphyxiation • stiffness of jaw (also called lockjaw) • stiffness of abdominal and back muscles • contraction of facial muscles • fast pulse • fever • sweating Dr.T.V.RaoMD 18
  • 19. 19 Patient Manifests with • A person suffering from tetanus undergoes convulsive muscle contractions of the jaw-- called LOCKJAW • The contractions by the muscles of the back and extremities may become so violent and strong that bone fractures may occur • The affected individual is conscious throughout the illness, but cannot stop these contractions
  • 21. The back muscles are more powerful, thus creating the arc backward “Oposthotonus” by Sir Charles Bell, 1809. Baby has neonatal tetanus with complete rigidity Dr.T.V.RaoMD 21
  • 22. 22 Types of tetanus: local, cephalic, generalized, neonatal • Incubation period: 3-21 days, average 8 days. Uncommon types: • Local tetanus: persistent muscle contractions in the same anatomic area as the injury, which will however subside after many weeks; very rarely fatal; milder than generalized tetanus, although it could precede it. • Cephalic tetanus: occurs with ear infections or following injuries of the head; facial muscles contractions.
  • 23. 23 Most common types: Generalized tetanus - descending pattern: lockjaw  stiffness of neck  difficulty swallowing  rigidity of abdominal and back muscles. - Spasms continue for 3-4 weeks, and recovery can last for months - Death occurs when spasms interfere with respiration. Neonatal tetanus: - Form of generalized tetanus that occurs in newborn infants born without protective passive immunity because the mother is not immune. - Usually occurs through infection of the unhealed umbilical stump, particularly when the stump is cut with an unsterile instrument.
  • 24. 24 Methods of diagnosis • Based on the patient’s account and physical findings that are characteristic of the disease. • Diagnostic studies generally are of little value, as cultures of the wound site are negative for C. tetani two- thirds of the time. –When the culture is positive, it confirms the diagnosis of tetanus
  • 25. Dr.T.V.RaoMD 25 Diagnosis • Tests that may be performed include the following: –Culture of the wound site (may be negative even if tetanus is present) –Tetanus antibody test –Other tests may be used to rule out meningitis, rabies, strychnine poisoning, or other diseases with similar symptoms.
  • 26. 26 Clinical treatment • If treatment is not sought early, the disease is often fatal. • The bacteria are killed with antibiotics, such as penicillin or tetracycline; further toxin production is thus prevented. • The toxin is neutralized with shots of tetanus immune globulin, TIG. • Other drugs may be given to provide sedation, relax the muscles and relieve pain. • Due to the extreme potency of the toxin, immunity does not result after the disease.
  • 27. years. Method of prevention - Immunization • A person recovering from tetanus should begin active immunization with tetanus toxoid (Td) during convalescence. • The tetanus toxoid is a formalin-inactivated toxin, with an efficiency of approx. 100%. • The DTaPe includes tetanus, diphtheria and pertussis toxoids; it is routinely given in the US during childhood. After 7 years of age, only Td needs to be administered. • Because the antitoxin levels decrease over time, booster immunization shots are needed every 10 29
  • 28. Dr.T.V.RaoMD 28 Other supporting measures? • Remove and destroy the source of the toxin through surgical exploration and cleaning of the wound (debridement). • Bed rest with a nonstimulating environment (dim light, reduced noise, and stable temperature) may be recommended. • Sedation may be necessary to keep the affected person calm. • Respiratory support with oxygen, endotracheal tube, and mechanical ventilation may be necessary.
  • 29. Dr.T.V.RaoMD 29 Specific Treatment b. Wound should be debrided widely. c. Maintain an adequate airway. d. Employ sedation (as indicated) or muscle. relaxant. e. Active immunization. should be initiated concurrently with therapy. 6.Destruction of environmental spores: - esp. in operating theatres. - Special air-flow equipment and filtered ventilation. - Reduce airborne particles. Surgical instruments and dressing sterilization (use of autoclaves). Disinfect. e.g. formaldehyde.
  • 30. Dr.T.V.RaoMD 30 Tetanus Toxoid • Formalin-inactivated tetanus toxin • Schedule Three or four doses + booster Booster every 10 years • Efficacy Approximately 100% • Duration Approximately 10 years • Should be administered with diphtheria toxoid as DTaP,DT, Td, or Tdap
  • 31. Prognosis in Infected • Prognosis is dependent on incubation period, time from spore inoculation to first symptom, and time from first symptom to first tetanic spasm. • In general, shorter intervals indicate more severe tetanus and a poorer prognosis. • Patients usually survive tetanus and return to their pre disease state of health. • Recovery is slow and usually occurs over 2-4 months. • Clinical tetanus does not produce a state of immunity; therefore, patients who survive the disease require active immunization with tetanus toxoid to prevent a recurrence.
  • 32. Dr.T.V.RaoMD 32 Care in the Hospital to eliminate C.tetani spores .Destruction of environmental spores: - Specially in operating theatres. - Special air-flow equipment and filtered ventilation. - Reduce airborne particles. Surgical instruments and dressing sterilization (use of autoclaves). Disinfect. e.g. formaldehyde.
  • 33. Tetanus is a Vaccine Preventable Disease- Do vaccinate without fail Dr.T.V.RaoMD 33